65 related articles for article (PubMed ID: 33335896)
1. A mechanistic updated overview on Cepharanthine as potential anticancer agent.
Wang Y; Wang T; Wang H; Liu W; Li X; Wang X; Zhang Y
Biomed Pharmacother; 2023 Sep; 165():115107. PubMed ID: 37423171
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous melanoma and purinergic modulation by phenolic compounds.
de Carvalho Braga G; Coiado JV; de Melo VC; Loureiro BB; Bagatini MD
Purinergic Signal; 2024 Mar; ():. PubMed ID: 38498100
[TBL] [Abstract][Full Text] [Related]
3. Effect of Cepharanthine on the Stemness of Lung Squamous Cell Carcinoma Based on Network Pharmacology and Bioinformatics.
Liu B; Deng JX
Biomed Res Int; 2022; 2022():5956526. PubMed ID: 36483630
[TBL] [Abstract][Full Text] [Related]
4. The Lysosome in Malignant Melanoma: Biology, Function and Therapeutic Applications.
Hsu CH; Lee KJ; Chiu YH; Huang KC; Wang GS; Chen LP; Liao KW; Lin CS
Cells; 2022 Apr; 11(9):. PubMed ID: 35563798
[TBL] [Abstract][Full Text] [Related]
5. Current status and future challenges in extraction, purification and identification of Cepharanthine (a potential drug against COVID-19).
Wang Y; Zhou X; Wei S; Wang G; Xi J
Sep Purif Technol; 2023 Mar; 309():123038. PubMed ID: 36593875
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Impact of Autophagy Biomarkers for Cutaneous Melanoma.
Tang DY; Ellis RA; Lovat PE
Front Oncol; 2016; 6():236. PubMed ID: 27882308
[TBL] [Abstract][Full Text] [Related]
7. Cepharanthine as a Potential Novel Tumor-Regional Therapy in Treating Cutaneous Melanoma: Altering the Expression of Cathepsin B, Tumor Suppressor Genes and Autophagy-Related Proteins.
Liu Y; Xie Y; Lin Y; Xu Q; Huang Y; Peng M; Lai W; Zheng Y
Front Bioeng Biotechnol; 2020; 8():601969. PubMed ID: 33335896
[TBL] [Abstract][Full Text] [Related]
8. Cepharanthine exerts antitumor activity on choroidal melanoma by reactive oxygen species production and c-Jun N-terminal kinase activation.
Zhu Q; Guo B; Chen L; Ji Q; Liang H; Wen N; Zhang L
Oncol Lett; 2017 May; 13(5):3760-3766. PubMed ID: 28529590
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel autophagic inhibitor cepharanthine to enhance the anti-cancer property of dacomitinib in non-small cell lung cancer.
Tang ZH; Cao WX; Guo X; Dai XY; Lu JH; Chen X; Zhu H; Lu JJ
Cancer Lett; 2018 Jan; 412():1-9. PubMed ID: 29024815
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of MYO1C mediated by cepharanthine inhibits autophagosome-lysosome fusion through blockade of the F-actin network.
Zhang Y; Jiang X; Deng Q; Gao Z; Tang X; Fu R; Hu J; Li Y; Li L; Gao N
J Exp Clin Cancer Res; 2019 Nov; 38(1):457. PubMed ID: 31699152
[TBL] [Abstract][Full Text] [Related]
11. Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
Rattanawong A; Payon V; Limpanasittikul W; Boonkrai C; Mutirangura A; Wonganan P
Oncol Rep; 2018 Jan; 39(1):227-238. PubMed ID: 29138869
[TBL] [Abstract][Full Text] [Related]
12. Cepharanthine Induces Autophagy, Apoptosis and Cell Cycle Arrest in Breast Cancer Cells.
Gao S; Li X; Ding X; Qi W; Yang Q
Cell Physiol Biochem; 2017; 41(4):1633-1648. PubMed ID: 28359054
[TBL] [Abstract][Full Text] [Related]
13. T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAF
Barceló C; Sisó P; Maiques O; García-Mulero S; Sanz-Pamplona R; Navaridas R; Megino C; Felip I; Urdanibia I; Eritja N; Soria X; Piulats JM; Penin RM; Dolcet X; Matías-Guiu X; Martí RM; Macià A
J Invest Dermatol; 2020 Jun; 140(6):1253-1265. PubMed ID: 31877318
[TBL] [Abstract][Full Text] [Related]
14. Revisiting the role of autophagy in melanoma.
Li S; Song Y; Quach C; Nemecio D; Liang C
Autophagy; 2019 Oct; 15(10):1843-1844. PubMed ID: 31242070
[TBL] [Abstract][Full Text] [Related]
15. Cepharanthine: An update of its mode of action, pharmacological properties and medical applications.
Bailly C
Phytomedicine; 2019 Sep; 62():152956. PubMed ID: 31132753
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
